LILLY 4165 (Evista 60 mg)
Generic Name: raloxifene
Pill imprint LILLY 4165 has been identified as Evista 60 mg.
Evista is used in the treatment of breast cancer, prevention; prevention of osteoporosis; osteoporosis and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. Not for use in pregnancy. Evista 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LILLY 4165
- 60 mg
- 12.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
Selective estrogen receptor modulators
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Lilly, Eli and Company
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
|NDC Code||Manufacturer / Repackager|
|54569-4628||A-S Medication Solutions, LLC (repackager)|
|54868-4170||Physicians Total Care Inc (repackager)|
|55289-0266||PDRX Pharmaceuticals Inc (repackager)|
|49999-0458||Lake Erie Medical and Surgical Supply (repackager)|
|68258-5987||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about Evista (raloxifene)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.